How J&J Leads Healthcare Innovation Through Sustainability

For more than 140 years, Johnson & Johnson (J&J) has positioned itself as a leader in healthcare innovation, working to support people's wellbeing across all life stages.

Since its early days at the 1876 World's Fair, through to ground-breaking advances in medicine, medical technologies and public health, the company has contributed to shaping the modern healthcare landscape.

The organisation's extensive history features recognisable products, forward-thinking leadership and an ongoing commitment to enhancing health and quality of life for people across the globe.

Sustainable and responsible practices

According to J&J, the company is dedicated to advancing global health through innovation in medicine and medical technologies, as well as by promoting sustainable, responsible and equitable practices throughout its operations and value chain.

"A healthy planet and a healthy community go hand in hand, and sustainability is about managing our personal, business and societal impacts to ensure better outcomes for patients and society," writes J&J on its website.

The company incorporates environmental, social and governance (ESG) principles into all aspects of its business, concentrating on areas where it could have the most significant impact: championing global health equity, empowering employees and protecting environmental health.

Through programmes such as J&J CareCommunity, Impact Ventures and global health equity initiatives, the organisation works to expand access to quality care, supports nurses and community health workers and invests in early-stage companies that could transform healthcare affordability and delivery.

"At Johnson & Johnson, we care for the planet like our collective health depends on it … because it does," says Paulette Frank, Chief Sustainability Officer, Johnson & Johnson.

Paulette Frank ranked 34 in Sustainability Magazine's Top 250 Leaders, read the full list here.

The company also addresses disaster relief requirements and works to strengthen health systems to support long-term resilience, prioritising the wellbeing of communities and health workers.

Regarding environmental efforts, J&J is working towards decarbonising its operations and value chains, advancing sustainable products and solutions and collaborating with others to promote sustainable healthcare.

By embedding accountability, innovation and ethical business practices across its operations, the company aims to create a cycle of social, environmental and economic value, working towards healthier communities, a stronger planet and a more equitable future.

Addressing complex health challenges

According to J&J, the company addresses pervasive and complex health challenges by combining rigorous science, breakthrough innovation and a commitment to patients.

Through its medicines and advanced medical technologies, J&J focuses on critical needs across oncology, cardiovascular care, neuroscience, immunology, orthopaedics, surgery and vision.

In biology and technology, the organisation develops solutions that could be smarter, less invasive and more personalised, from robotic-assisted surgery and precision catheters to heart pumps, circulatory restoration technologies and vision innovations.

According to J&J, these innovations could be particularly important in surgery, where more than 50 million people globally are impacted by surgical site infections, which account for 20% to 31% of all hospital-acquired infections and up to 16% of patients experience disruptive bleeding, driving costs of up to US$10bn annually in the US alone.

By developing solutions that aim to deliver care with precision, protect healthy tissue and reimagine healing across the full cycle of care, J&J is working to move beyond treating symptoms to improve outcomes, restore quality of life and help build a healthier future for patients worldwide.

"At Johnson & Johnson, we are leading where medicine is going, with a relentless focus on bringing transformational medical innovation to patients who are waiting," says Jennifer L. Taubert, Executive Vice President, Worldwide Chairman, Innovative Medicine, Johnson & Johnson.

"Our team's deep expertise and global reach are helping us reimagine how devastating diseases are treated and cured, delivering hope and better care for millions of patients and their families around the world."

Collaborating with supply partners

According to J&J, the company views its suppliers as vital partners in advancing global healthcare.

By developing relationships based on trust, transparency and shared innovation, J&J integrates suppliers into its network as an extension of its capabilities, utilising their expertise to co-create solutions that could address unmet patient need.

All sustainability, net zero and sustainable supply chain leaders should attend:

• Sustainability LIVE: The Net Zero Summit - QEII Centre, London, March 4-5
• Sustainability LIVE: The US Summit - Navy Pier, Chicago, April 21-22

Co-located with Procurement & Supply Chain LIVE, these events brings together CSOs, ESG leaders and senior decision-makers at a moment when sustainability, supply chains and commercial performance are increasingly interconnected.

Tickets can be booked online today for The Net Zero Summit and The US Summit. Group discounts available.

In hospital supply chains, the company works to optimise people, processes and technology, providing training and support, applying lean methodologies to improve workflows and using technology-enabled tools like radio-frequency identification (RFID) and barcode scanning to simplify ordering, tracking and inventory management.

By aligning supplier-enabled innovation with the challenges of healthcare delivery, J&J aims to ensure that hospitals and providers have the resources and solutions they need to improve patient outcomes, reduce costs and advance a healthier world.